Khosroshahi Hamid T, Shoja Mohammadali M, Azar Sima Abedi, Tubbs R Shane, Safa Javid, Etemadi Jalal, Ardalan Mohammad R
Department of Nephrology, Tabriz University of Medical Sciences, Tabriz, Iran.
Exp Clin Transplant. 2007 Dec;5(2):670-2.
This study sought to elucidate the status of calcium, phosphorus, and parathyroid hormone in patients following kidney transplant.
In this cross-sectional study, 20 renal transplant recipients were evaluated. For each patient, age, sex, time since transplant, and body weight were recorded. Inclusion criteria were age > 14 years and good allograft function defined as a serum creatinine level < 132.6 micromol/L for at least 6 months after transplant. Exclusion criteria were immunosuppressive therapy other than the standard triple regimen (cyclosporine, prednisolone, and mycophenolate mofetil or azathioprine) and use of any drug known to alter calcium hemostasis. Levels of 24-hour urine calcium, phosphorus, creatinine, and uric acid, as well as concentrations of hemoglobin, serum creatinine, calcium, and phosphorus were measured. To obtain a mean value of serum intact parathyroid hormone in transplant recipients at our center, serum intact parathyroid hormone levels were additionally quantitated in another group of 30 renal transplant recipients.
The mean hemoglobin level was 135.6 +/- 17.7 g/L, the mean serum creatinine level was 105.0 +/- 15.3 micromol/L, and the mean serum calcium and phosphorus levels were 2.25 +/- 0.17 mmol/L (normal range, 2.02-2.60 mmol/L) and 1.28 +/- 0.24 mmol/L (normal range, 0.81-1.61 mmol/L), respectively. The mean serum intact parathyroid hormone level was 33.17 +/- 14.67 ng/L (normal range, 10-60 ng/L). Mean 24-hour urine calcium and phosphorus values were 2.32 +/- 1.68 mmol/day (normal, 2.49-6.24 mmol/day) and 19.77 +/- 8.31 mmol/day (normal, 12.91-41.98 mmol/day), respectively. A positive correlation was found between serum calcium and alkaline phosphatase levels (r = +0.71, P = .006). Hemoglobin level was negatively correlated with serum phosphorus level (r = -0.65, P = .003) and sex (r = -0.57, P = .003) and positively correlated with urine creatinine levels (r = +0.69, P = .001).
Renal transplant recipients with stable allograft function may have normal serum calcium, phosphorus, and intact parathyroid hormone levels. However, presence of hypocalciuria and elevated serum alkaline phosphatase levels might imply impaired calcium metabolism in these patients.
本研究旨在阐明肾移植患者钙、磷及甲状旁腺激素的状况。
在这项横断面研究中,对20例肾移植受者进行了评估。记录每位患者的年龄、性别、移植后的时间及体重。纳入标准为年龄>14岁且移植后至少6个月内移植肾功能良好,定义为血清肌酐水平<132.6微摩尔/升。排除标准为除标准三联疗法(环孢素、泼尼松龙及霉酚酸酯或硫唑嘌呤)以外的免疫抑制治疗以及使用任何已知会改变钙稳态的药物。测定24小时尿钙、磷、肌酐及尿酸水平,以及血红蛋白、血清肌酐、钙和磷的浓度。为获得本中心肾移植受者血清完整甲状旁腺激素的平均值,在另一组30例肾移植受者中额外测定了血清完整甲状旁腺激素水平。
平均血红蛋白水平为135.6±17.7克/升,平均血清肌酐水平为105.0±15.3微摩尔/升,平均血清钙和磷水平分别为2.25±0.17毫摩尔/升(正常范围2.02 - 2.60毫摩尔/升)和1.28±0.24毫摩尔/升(正常范围0.81 - 1.61毫摩尔/升)。平均血清完整甲状旁腺激素水平为33.17±14.67纳克/升(正常范围10 - 60纳克/升)。24小时尿钙和磷的平均值分别为2.32±1.68毫摩尔/天(正常范围2.49 - 6.24毫摩尔/天)和19.77±8.31毫摩尔/天(正常范围12.91 - 41.98毫摩尔/天)。血清钙与碱性磷酸酶水平呈正相关(r = +0.71,P = .
006)。血红蛋白水平与血清磷水平呈负相关(r = -0.65,P = .003),与性别呈负相关(r = -0.57,P = .003),与尿肌酐水平呈正相关(r = +0.69,P = .001)。
移植肾功能稳定的肾移植受者血清钙、磷及完整甲状旁腺激素水平可能正常。然而,低钙尿症及血清碱性磷酸酶水平升高可能意味着这些患者存在钙代谢受损。